ZD6474, Vandetanib

DRUG2 trials

Sponsors

Genzyme, a Sanofi Company

Conditions

Ampullary CarcinomaBiliary Tract CancerCancer Of The Extrahepatic Bile DuctGallbladder CancerNon Small Cell Lung Cancer

Phase 2

Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus Gemcitabine

CompletedNCT00753714

Genzyme, a Sanofi CompanyNon Small Cell Lung Cancer

Start: 2008-10-31End: 2011-12-31Updated: 2016-10-17

Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer

CompletedNCT00753675

Genzyme, a Sanofi CompanyAmpullary Carcinoma, Biliary Tract Cancer, Cancer Of The Extrahepatic Bile Duct +1

Start: 2008-10-31End: 2012-09-30Updated: 2016-10-10

Related Papers

A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study.

2014-12-2382 citations